Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FK700
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,173
Award facts
- Contract value 100% obligated
- $38,172.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $38,172.93 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on December 17, 2025, with an ultimate completion date of December 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is fulfilling this order under its broader relationship with the DLA as a critical supplier of pharmaceutical products and medical supplies to federal healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products, brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs worldwide. RINVOQ ER, an inflammatory bowel disease treatment, represents one of the specialized medications included within the company's portfolio of deliveries across multiple therapeutic domains serving the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FK700?
SPE2DR26FK700 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26FK700 worth?
The government has obligated $38,173 on SPE2DR26FK700.
Is contract SPE2DR26FK700 an order under another contract?
Yes. SPE2DR26FK700 is a delivery order under SPE2DR25D1104, an indefinite delivery contract.
Was contract SPE2DR26FK700 competed?
The extent of competition for SPE2DR26FK700 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award